Current Affairs   »   Science & Technology Current Affairs 2022   »   Corbevax gets emergency approval for 12-18...

Corbevax gets emergency approval for 12-18 age group by DGCI

Corbevax Vaccine: Gets emergency approval for 12-18 age group by DGCI_50.1

The Drugs Controller General of India (DCGI) has approved the Corona Vaccine Biologicals E Ltd’s Corbevax for children in the age group of 12 to 18 years. Hyderabad-based pharmaceutical company Biological E Ltd said its coronavirus vaccine Corbevax, is also India’s third homegrown vaccine. Bharat Biotech’s Covaxin is being given to children aged 15 to 18 years from January 3.

Buy Prime Test Series for all Banking, SSC, Insurance & other exams

About the Corbevax:

Corbevax is called a protein subunit and currently, we have an example of the hepatitis B vaccine which is also similarly a protein subunit vaccine. Corbevax and the other vaccine in India, we have Covovax from Serum Institute.

Find More Sci-Tech News Here

Corbevax Vaccine: Gets emergency approval for 12-18 age group by DGCI_60.1

Corbevax Vaccine: Gets emergency approval for 12-18 age group by DGCI_70.1

Thank You, Your details have been submitted we will get back to you.
Was this page helpful?

Leave a comment

Your email address will not be published. Required fields are marked *